Show simple item record

Efecto citotóxico de fosfolipasas A2 del veneno de Crotalus durissus cumanensis de Colombia

dc.contributor.authorQuintana-Castillo, Juan Carlosspa
dc.contributor.authorÁvila-Gómez, Isabel Cristinaspa
dc.contributor.authorCeballos-Ruiz, Juan Felipespa
dc.contributor.authorVargas-Muñoz, Leidy Johanaspa
dc.contributor.authorEstrada-Gómez, Sebastiánspa
dc.date.accessioned2017-06-15 00:00:00
dc.date.accessioned2022-03-08T16:18:21Z
dc.date.available2017-06-15 00:00:00
dc.date.available2022-03-08T16:18:21Z
dc.date.issued2017-06-15
dc.identifier.issn2389-7325
dc.identifier.urihttps://repositorio.uniboyaca.edu.co/handle/uniboyaca/316
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Boyacáspa
dc.rightsRevista Investigación en Salud Universidad de Boyacá - 2017spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/view/194spa
dc.subjectCrotalus durissus cumanensisspa
dc.subjectcitotoxicidadspa
dc.subjectfosfolipasas A2spa
dc.subjectcrotoxina Bspa
dc.subjectCrotalus durissus cumanensiseng
dc.subjectcitotoxicityeng
dc.subjectphospholipases A2eng
dc.subjectcrotoxin Beng
dc.subjectCrotalus durissus cumanesiseng
dc.subjectcitotoxicidadeeng
dc.subjectfosfolipases A2eng
dc.subjectCrotoxina Beng
dc.titleEfecto citotóxico de fosfolipasas A2 del veneno de Crotalus durissus cumanensis de Colombiaspa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.identifier.doi10.24267/23897325.194
dc.identifier.eissn2539-2018
dc.identifier.urlhttps://doi.org/10.24267/23897325.194
dc.relation.bitstreamhttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/download/194/231
dc.relation.citationeditionNúm. 1 , Año 2017 : Revista Investigación en Salud Universidad de Boyacáspa
dc.relation.citationendpage37
dc.relation.citationissue1spa
dc.relation.citationstartpage16
dc.relation.citationvolume4spa
dc.relation.ispartofjournalRevista Investigación en Salud Universidad de Boyacáspa
dc.relation.referencesCalderon LA, Sobrinho JC, Zaqueo KD, de Moura AA, Grabner AN, Mazzi MV, et al. Antitumoral activity of snake venom proteins: New trends in cancer therapy. Biomed Res Int. 2014;2014:203639.spa
dc.relation.referencesWeinberg R. The biology of cancer. Second edition. EE.UU: Taylor and Francis Group; 2013. 960 p.spa
dc.relation.referencesRiss TL, Moravec RA. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol. 2004;2:51-62.spa
dc.relation.referencesAndriao-Escarso SH, Soares AM, Rodrigues VM, Angulo Y, Diaz C, Lomonte B, et al. Myotoxic phospholipases A(2) in bothrops snake venoms: Effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. Biochimie. 2000;82:755-63.spa
dc.relation.referencesCecilio AB, Caldas S, Oliveira RA, Santos AS, Richardson M, Naumann GB, et al. Molecular characterization of Lys49 and Asp49 phospholipases A(2) from snake venom and their antiviral activities against dengue virus. Toxins. 2013;5:1780-98.spa
dc.relation.referencesMuller VD, Russo RR, Cintra AC, Sartim MA, Alves-Paiva RdeM, Figueiredo LT, et al. Crotoxin and phospholipases A(2) from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses. Toxicon. 2012;59:507-15.spa
dc.relation.referencesMurillo LA, Lan CY, Agabian NM, Larios S, Lomonte B. Fungicidal activity of a phospholipase-A2-derived synthetic peptide variant against Candida albicans. Rev Esp Quimioter. 2007;20:330-3.spa
dc.relation.referencesQuintana JC, Chacón AM, Vargas L, Segura C, Gutiérrez JM, Alarcón JC. Antiplasmodial effect of the venom of Crotalus durissus cumanensis, crotoxin complex and crotoxin B. Acta Trop. 2012;124:126-32.spa
dc.relation.referencesSix DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: Classification and characterization. Biochim Biophys Acta. 2000;1488:1-19.spa
dc.relation.referencesEvangelista IL, Martins AM, Nascimento NR, Havt A, Evangelista JS, de Noroes TB, et al. Renal and cardiovascular effects of Bothrops marajoensis venom and phospholipase A2. Toxicon. 2010;55:1061-70.spa
dc.relation.referencesKini RM. Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon. 2003;42:827-40.spa
dc.relation.referencesLanducci EC, de Castro RC, Toyama M, Giglio JR, Marangoni S, De Nucci G, et al. Inflammatory oedema induced by the lys-49 phospholipase A(2) homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide. Biochem Pharmacol. 2000;59:1289-94.spa
dc.relation.referencesBarbosa PS, Martins AM, Havt A, Toyama DO, Evangelista JS, Ferreira DP, et al. Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom. Toxicon. 2005;46:376-86.spa
dc.relation.referencesKini RM, Evans HJ. Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2. J Biol Chem. 1987;262:14402-7.spa
dc.relation.referencesde Moura AA, Kayano AM, Oliveira GA, Setubal SS, Ribeiro JG, Barros NB, et al. Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells. Biomed Res Int. 2014;195356.spa
dc.relation.referencesNelson J, Barlow K, Beck DO, Berbert A, Eshenroder N, Francom L, et al. Synergistic effects of secretory phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus with cancer chemotherapeutic agents. Biomed Res Int. 2013;565287.spa
dc.relation.referencesSamel M, Vija H, Kurvet I, Kunnis-Beres K, Trummal K, Subbi J, et al. Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells. Toxins. 2013;5:203-23.spa
dc.relation.referencesLaemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.spa
dc.relation.referencesGutiérrez JM, Ávila C, Rojas E, Cerdas L. An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon. 1988;26:411-3.spa
dc.relation.referencesHabermann E, Hardt KL. A sensitive and specific plate test for the quantitation of phospholipases. Analyt Biochem. 1972;50:1963-5.spa
dc.relation.referencesLomonte B, Gutiérrez JM, Romero M, Nunez J, Tarkowski A, Hanson LA. An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. J Immunol Methods. 1993;161:231-7.spa
dc.relation.referencesBouchier C, Ducancel F, Guignery-Frelat G, Bon C, Boulain JC, Menez A. Cloning and sequencing of cDNAs encoding the two subunits of Crotoxin. Nucleic Acid Res. 1988;16:9050.spa
dc.relation.referencesAzevedo-Marques MM, Cupo P, Coimbra TM, Hering SE, Rossi MA, Laure CJ. Myonecrosis, myoglobinuria and acute renal failure induced by South American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon. 1985;23:631-6.spa
dc.relation.referencesCupo P, Azevedo-Marques MM, Hering SE. Clinical and laboratory features of South American rattlesnake (Crotalus durissus terrificus) envenomation in children. Trans R Soc Trop Med Hyg. 1988;82:924-9.spa
dc.relation.referencesMartins AM, Toyama MH, Havt A, Novello JC, Marangoni S, Fonteles MC, et al. Determination of Crotalus durissus cascavella venom components that induce renal toxicity in isolated rat kidneys. Toxicon. 2002;40:1165-71.spa
dc.relation.referencesOshima-Franco Y, Hyslop S, Prado-Franceschi J, Cruz-Hofling MA, Rodrigues-Simioni L. Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and its main toxin, crotoxin. Toxicon. 1999;37:1341-57.spa
dc.relation.referencesCosta AF, Dantas RT, Toyama MH, Diz Filho E, Zara FJ, Rodrigues MG, et al. Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: Phospholipase A2 and L-amino acid oxidase. Toxicon. 2010;55:795-804.spa
dc.relation.referencesMurakami MT, Arruda EZ, Melo PA, Martínez AB, Calil-Elias S, Tomaz MA, et al. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. J Mol Biol. 2005;350:416-26.spa
dc.relation.referencesFaure G, Xu H, Saul FA. Crystal structure of crotoxin reveals key residues involved in the stability and toxicity of this potent heterodimeric beta-neurotoxin. J Mol Biol. 2011;412:176-91.spa
dc.relation.referencesFaure G, Bon C. Several isoforms of crotoxin are present in individual venoms from the South American rattlesnake Crotalus durissus terrificus. Toxicon. 1987;25:229-34.spa
dc.relation.referencesHendon RA, Fraenkel-Conrat H. Biological roles of the two components of crotoxin. Proc Natl Acad Sci U S A. 1971;68:1560-3.spa
dc.relation.referencesFagundes FH, Oliveira M, Huancahuire-Vega S, Romero-Vargas FF, Ponce-Soto LA, Marangoni S. cDNA and deduced primary structure of basic phospholipase A2 with neurotoxic activity from the venom secretion of the Crotalus durissus collilineatus rattlesnake. Braz J Med Biol Res. 2010;43:262-70.spa
dc.relation.referencesPonce-Soto LA, Baldasso PA, Romero-Vargas FF, Winck FV, Novello JC, Marangoni S. Biochemical, pharmacological and structural characterization of two PLA2 isoforms Cdr-12 and Cdr-13 from Crotalus durissus ruruima snake venom. Protein J. 2007;26:39-49.spa
dc.relation.referencesPonce-Soto LA, Lomonte B, Rodrigues-Simioni L, Novello JC, Marangoni S. Biological and structural characterization of crotoxin and new isoform of crotoxin B PLA(2) (F6a) from Crotalus durissus collilineatus snake venom. Protein J. 2007;26:221-30.spa
dc.relation.referencesCosta LA, Miles H, Araujo CE, González S, Villarrubia VG. Tumor regression of advanced carcinomas following intra- and/ or peri-tumoral inoculation with VRCTC- 310 in humans: Preliminary report of two cases. Immunopharmacol Immunotoxicol. 1998;20:15-25.spa
dc.relation.referencesCosta LA, Miles HA, Diez RA, Araujo CE, Coni CM, Cervellino JC. Phase I study of VRCTC- 310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: Safety and pharmacokinetic data. Anticancer Drugs. 1997;8:829-34.spa
dc.relation.referencesFinn R. Snake venom protein paralyzes cancer cells. J Natl Cancer Inst. 2001;93:261-2.spa
dc.relation.referencesHe JK, Wu XS, Wang Y, Han R, Qin ZH, Xie Y. Growth inhibitory effects and molecular mechanisms of crotoxin treatment in esophageal Eca-109 cells and transplanted tumors in nude mice. Acta Pharmacol Sin. 2013;34:295- 300.spa
dc.relation.referencesKim DS, Jang YJ, Jeon OH, Kim DS. Saxatilin, a snake venom disintegrin, suppresses TNF-alpha-induced ovarian cancer cell invasion. J Biochem Mol Biol. 2007;40:290-4.spa
dc.relation.referencesYan CH, Yang YP, Qin ZH, Gu ZL, Reid P, Liang ZQ. Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacol Sin. 2007;28:540-8.spa
dc.relation.referencesNewman RA, Vidal JC, Viskatis LJ, Johnson J, Etcheverry MA. VRCTC-310--a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest New Drugs. 1993;11:151-9.spa
dc.relation.referencesVadas P. Group II phospholipases A2 are indirectly cytolytic in the presence of exogenous phospholipid. Biochim Biophys Acta. 1997;1346:193-7.spa
dc.relation.referencesLomonte B, Angulo Y, Calderón L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon. 2003;42:885-901.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.title.translatedCytotoxic effect of A2 phospholipases of the venom of Crotalus durissus cumanensis from Colombiaeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Files in this item

FilesSizeFormatView
Revista Investig. Salud Univ. Boyacá-194.pdf1.301Mbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record

Revista Investigación en Salud Universidad de Boyacá - 2017
Except where otherwise noted, this item's license is described as Revista Investigación en Salud Universidad de Boyacá - 2017